Your browser is no longer supported. Please, upgrade your browser.
Settings
AMPH Amphastar Pharmaceuticals, Inc. daily Stock Chart
AMPH [NASD]
Amphastar Pharmaceuticals, Inc.
Index- P/E445.11 EPS (ttm)0.05 Insider Own6.40% Shs Outstand48.03M Perf Week-1.91%
Market Cap962.04M Forward P/E21.42 EPS next Y0.94 Insider Trans-4.50% Shs Float35.20M Perf Month-1.18%
Income2.30M PEG17.80 EPS next Q0.04 Inst Own48.80% Short Float3.78% Perf Quarter-2.67%
Sales316.10M P/S3.04 EPS this Y-264.00% Inst Trans0.39% Short Ratio7.55 Perf Half Y-8.46%
Book/sh7.17 P/B2.79 EPS next Y204.56% ROA- Target Price25.25 Perf Year23.57%
Cash/sh1.71 P/C11.75 EPS next 5Y25.00% ROE- 52W Range16.18 - 25.43 Perf YTD0.65%
Dividend- P/FCF- EPS past 5Y-19.70% ROI-1.40% 52W High-21.79% Beta1.34
Dividend %- Quick Ratio1.40 Sales past 5Y5.10% Gross Margin38.30% 52W Low22.93% ATR0.52
Employees2078 Current Ratio2.10 Sales Q/Q36.60% Oper. Margin- RSI (14)39.36 Volatility2.14% 2.57%
OptionableYes Debt/Eq0.15 EPS Q/Q111.20% Profit Margin- Rel Volume0.32 Prev Close20.03
ShortableYes LT Debt/Eq0.09 EarningsAug 08 AMC Payout- Avg Volume176.05K Price19.89
Recom2.30 SMA20-3.31% SMA50-3.76% SMA200-5.08% Volume38,997 Change-0.70%
Mar-13-19Downgrade Piper Jaffray Overweight → Neutral $24 → $23
Mar-13-19Downgrade Needham Buy → Hold
Aug-10-18Reiterated Needham Buy $24 → $22
Mar-13-18Reiterated Needham Buy $23 → $24
Dec-01-17Reiterated Needham Buy $20 → $23
Nov-09-17Downgrade Raymond James Outperform → Mkt Perform
Sep-27-17Reiterated Needham Buy $18 → $20
Mar-14-17Downgrade Raymond James Strong Buy → Outperform
Aug-09-16Reiterated Needham Buy $20 → $22
May-10-16Reiterated Needham Buy $21 → $20
Feb-19-16Initiated Wells Fargo Outperform
Jun-19-15Reiterated Needham Buy $17 → $21
Jun-03-15Initiated Raymond James Strong Buy
Jul-21-14Initiated Needham Buy $17
Jun-29-19 06:18PM  Is Amphastar Pharmaceuticals Inc (AMPH) A Good Stock To Buy ? Insider Monkey
Jun-24-19 06:00AM  Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference GlobeNewswire
Jun-19-19 06:00AM  Amphastar Pharmaceuticals, Inc. Announces Settlement in Litigation with Momenta and Sandoz GlobeNewswire
Jun-14-19 02:07PM  Introducing Amphastar Pharmaceuticals (NASDAQ:AMPH), A Stock That Climbed 33% In The Last Three Years Simply Wall St.
06:00AM  Amphastar Pharmaceuticals to Present at the Raymond James Life Sciences and MedTech Healthcare Conference GlobeNewswire
May-31-19 06:00AM  Amphastar Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference GlobeNewswire
May-28-19 02:47PM  7 Stocks to Buy for June InvestorPlace
May-21-19 01:33AM  Edited Transcript of AMPH earnings conference call or presentation 9-May-19 9:00pm GMT Thomson Reuters StreetEvents
May-10-19 06:00AM  Amphastar Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference 2019 GlobeNewswire
12:24AM  Amphastar Pharmaceuticals Inc (AMPH) Q1 2019 Earnings Call Transcript Motley Fool
May-09-19 07:05PM  Amphastar Pharmaceuticals (AMPH) Q1 Earnings and Revenues Surpass Estimates Zacks
05:58PM  Amphastar: 1Q Earnings Snapshot Associated Press
04:05PM  Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2019 GlobeNewswire
May-07-19 10:56AM  Heres What Hedge Funds Think About Amphastar Pharmaceuticals Inc (AMPH) Insider Monkey
May-06-19 06:00AM  Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2019 GlobeNewswire
May-01-19 10:33AM  Amphastar Pharmaceuticals (AMPH) to Report Q1 Results: Wall Street Expects Earnings Growth Zacks
Apr-26-19 09:30AM  MNK or AMPH: Which Is the Better Value Stock Right Now? Zacks
Apr-25-19 03:13PM  Do Insiders Own Shares In Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)? Simply Wall St.
Apr-15-19 09:30AM  Small Cap Pot Stocks Can Bring Investors High Profits-THC Therapeutics, Inc. ACCESSWIRE
Apr-10-19 09:30AM  MNK vs. AMPH: Which Stock Is the Better Value Option? Zacks
Mar-26-19 05:32PM  Amid talk of buyout, Peninsula biotech zeroes in on its blood-thinner antidote American City Business Journals
Mar-25-19 09:30AM  MNK vs. AMPH: Which Stock Should Value Investors Buy Now? Zacks
Mar-21-19 12:06AM  Edited Transcript of AMPH earnings conference call or presentation 12-Mar-19 9:00pm GMT Thomson Reuters StreetEvents
Mar-19-19 07:40AM  The Daily Biotech Pulse: FDA Nod For Roche And Amphastar, Milestone Payment Kicks In For Affimed Benzinga
06:00AM  Amphastar Pharmaceuticals Receives FDA Approval for Enoxaparin Sodium Injection 300mg/3mL (100mg/mL) Multiple Dose Vial GlobeNewswire
Mar-15-19 07:48AM  Amphastar Pharmaceuticals Inc (AMPH) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com
Mar-13-19 04:17PM  This Biotech Sees Markets Worth Billions But Can It Survive A 'Pause'? Investor's Business Daily -14.44%
10:24AM  Does Market Volatility Impact Amphastar Pharmaceuticals, Inc.s (NASDAQ:AMPH) Share Price? Simply Wall St.
02:36AM  Amphastar Pharmaceuticals (AMPH) Q4 2018 Earnings Conference Call Transcript Motley Fool
Mar-12-19 07:10PM  Amphastar Pharmaceuticals (AMPH) Beats Q4 Earnings and Revenue Estimates Zacks
06:16PM  Amphastar: 4Q Earnings Snapshot Associated Press
04:05PM  Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2018 GlobeNewswire
03:00PM  Amphastar Pharmaceuticals Inc to Host Earnings Call ACCESSWIRE
07:31AM  Amphastar Pharmaceutical Q4 Earnings Preview Benzinga
Mar-08-19 09:30AM  MNK vs. AMPH: Which Stock Should Value Investors Buy Now? Zacks
Mar-07-19 04:01PM  Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12, 2019 GlobeNewswire
Feb-26-19 08:15AM  Market Trends Toward New Normal in Micron Technology, Harris, Sientra, Noble, Amphastar Pharmaceuticals, and CECO Environmental Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Feb-13-19 09:30AM  MNK vs. AMPH: Which Stock Should Value Investors Buy Now? Zacks
Jan-29-19 01:38PM  Who Has Been Selling Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares? Simply Wall St.
Jan-28-19 09:30AM  MNK vs. AMPH: Which Stock Should Value Investors Buy Now? Zacks
Jan-11-19 09:30AM  MNK vs. AMPH: Which Stock Should Value Investors Buy Now? Zacks
Jan-03-19 06:00AM  Amphastar Pharmaceuticals, Inc. Announces Launch of Primatene® MIST to Nationwide Retail Pharmacies GlobeNewswire
Dec-25-18 09:30AM  BHC vs. AMPH: Which Stock Is the Better Value Option? Zacks
Dec-23-18 09:20PM  Is Amphastar Pharmaceuticals Inc (AMPH) A Good Stock To Buy? Insider Monkey
Dec-21-18 11:04AM  How Much Did Amphastar Pharmaceuticals, Inc.s (NASDAQ:AMPH) CEO Pocket Last Year? Simply Wall St.
Dec-03-18 08:52AM  Amphastar Pharmaceuticals (AMPH) Catches Eye: Stock Jumps 6.7% Zacks
Nov-27-18 08:45AM  New Research Coverage Highlights Phibro Animal Health, RadNet, Amphastar Pharmaceuticals, FibroGen, Sientra, and Flexion Therapeutics Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Nov-22-18 09:30AM  BHC or AMPH: Which Is the Better Value Stock Right Now? Zacks
Nov-21-18 10:42AM  What You Must Know About Amphastar Pharmaceuticals Incs (NASDAQ:AMPH) Financial Strength Simply Wall St.
Nov-20-18 04:05PM  Amphastar Pharmaceuticals to Present at the 30th Annual Piper Jaffray Healthcare Conference 2018 GlobeNewswire
Nov-14-18 03:47PM  Edited Transcript of AMPH earnings conference call or presentation 8-Nov-18 10:00pm GMT Thomson Reuters StreetEvents -5.09%
Nov-09-18 06:00AM  Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference 2018 GlobeNewswire
Nov-08-18 09:32PM  Amphastar Pharmaceuticals Inc (AMPH) Q3 2018 Earnings Conference Call Transcript Motley Fool +7.58%
08:40PM  Amphastar Pharmaceuticals (AMPH) Matches Q3 Earnings Estimates Zacks
07:33PM  Amphastar: 3Q Earnings Snapshot Associated Press
04:10PM  Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2018 GlobeNewswire
Nov-07-18 09:55PM  Amphastar Pharmaceuticals, Inc. Announces Reintroduction of Primatene® MIST GlobeNewswire
Nov-06-18 04:05PM  Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2018 GlobeNewswire
09:30AM  MNK or AMPH: Which Is the Better Value Stock Right Now? Zacks
Nov-02-18 04:05PM  Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2018 GlobeNewswire
Oct-16-18 09:15AM  Consolidated Research: 2018 Summary Expectations for Freightcar America, Star Bulk Carriers, Avis Budget Group, Adamas Pharmaceuticals, Model N, and Amphastar Pharmaceuticals Fundamental Analysis, Key Performance Indications GlobeNewswire
Oct-12-18 10:18AM  Who Are The Major Shareholders In Amphastar Pharmaceuticals Inc (NASDAQ:AMPH)? Simply Wall St.
Oct-02-18 09:30AM  MNK or AMPH: Which Is the Better Value Stock Right Now? Zacks
Sep-13-18 09:30AM  AKRX vs. AMPH: Which Stock Should Value Investors Buy Now? Zacks
Aug-29-18 04:05PM  Amphastar Pharmaceuticals to Present at the Wells Fargo Healthcare Conference 2018 GlobeNewswire
Aug-27-18 09:30AM  AKRX vs. AMPH: Which Stock Should Value Investors Buy Now? Zacks
Aug-23-18 03:40AM  Edited Transcript of AMPH earnings conference call or presentation 8-Aug-18 9:00pm GMT Thomson Reuters StreetEvents
Aug-20-18 08:00AM  Investor Expectations to Drive Momentum within Rapid7, 1-800 FLOWERS.COM, SMART Global, Prothena Corporation plc, Amphastar Pharmaceuticals, and Silvercorp Metals Discovering Underlying Factors of Influence GlobeNewswire
Aug-10-18 09:30AM  MNK vs. AMPH: Which Stock Should Value Investors Buy Now? Zacks
Aug-08-18 08:05PM  Amphastar Pharmaceuticals (AMPH) Misses Q2 Earnings Estimates Zacks
07:04PM  Amphastar: 2Q Earnings Snapshot Associated Press
04:05PM  Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2018 GlobeNewswire
03:00PM  Amphastar Pharmaceuticals Inc to Host Earnings Call ACCESSWIRE
Aug-03-18 06:00AM  Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2018 GlobeNewswire
Jul-09-18 06:00AM  Amphastar Announces Expansion of Amphastar Nanjing Pharmaceuticals Inc. GlobeNewswire
Jul-02-18 09:30AM  AGN vs. AMPH: Which Stock Is the Better Value Option? Zacks
Jun-19-18 06:00AM  Amphastar Announces Approval for Isoproterenol Hydrochloride Injection, USP GlobeNewswire
Jun-14-18 08:01AM  New Strong Sell Stocks for June 14th Zacks
Jun-05-18 08:00AM  Consolidated Research: 2018 Summary Expectations for Summit Therapeutics, Orbotech, Amphastar Pharmaceuticals, Mizuho Financial Group, Endo International plc, and AXT Fundamental Analysis, Key Performance Indications GlobeNewswire
05:21AM  Moving Average Crossover Alert: Amphastar Pharmaceuticals, Inc. (AMPH) Zacks
Jun-04-18 04:05PM  Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference 2018 GlobeNewswire
06:00AM  Amphastar Pharmaceuticals Receives FDA Approval for Semi-Purified Heparin at Amphastar Nanjing Pharmaceuticals GlobeNewswire
Jun-01-18 08:18AM  New Strong Sell Stocks for June 1st Zacks
May-31-18 06:42PM  Amphastar Pharmaceuticals Inc (NASDAQ:AMPH): Should The Recent Earnings Drop Worry You? Simply Wall St.
May-29-18 08:56AM  New Strong Sell Stocks for May 29th Zacks
May-22-18 10:23AM  New Strong Sell Stocks for May 22nd Zacks
May-18-18 08:39AM  Falling Earnings Estimates Signal Weakness Ahead for Amphastar (AMPH) Zacks
May-16-18 03:23PM  How Should You Think About Amphastar Pharmaceuticals Incs (NASDAQ:AMPH) Risks? Simply Wall St.
May-15-18 08:44AM  Benzinga's Daily Biotech Pulse: Aytu Rallies On Earnings, Evolus Awaits FDA Verdict, BofA Conference Underway Benzinga
08:19AM  New Strong Sell Stocks for May 15th Zacks
May-14-18 09:41PM  Edited Transcript of AMPH earnings conference call or presentation 9-May-18 9:00pm GMT Thomson Reuters StreetEvents +8.12%
06:00AM  Amphastar Pharmaceuticals Receives FDA Approval for Calcium Chloride Injection GlobeNewswire
May-10-18 06:00AM  Amphastar Pharmaceuticals to Present at the Bank of America Merrill Lynch Health Care Conference 2018 GlobeNewswire -24.70%
May-09-18 06:23PM  Amphastar: 1Q Earnings Snapshot Associated Press
04:05PM  Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2018 GlobeNewswire
May-03-18 04:05PM  Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2018 GlobeNewswire
Apr-27-18 05:22PM  Is Amphastar Pharmaceuticals Incs (NASDAQ:AMPH) Balance Sheet Strong Enough To Weather A Storm? Simply Wall St.
Apr-12-18 08:30AM  Consolidated Research: 2018 Summary Expectations for Insight Enterprises, Amphastar Pharmaceuticals, EMC Insurance Group, Prothena Corporation plc, Mizuho Financial Group, and Baytex Energy Fundamental Analysis, Key Performance Indications GlobeNewswire
Apr-04-18 10:55AM  What Is Amphastar Pharmaceuticals Incs (NASDAQ:AMPH) Share Price Doing? Simply Wall St.
Mar-28-18 09:08AM  Is Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) A Sell At Its Current PE Ratio? Simply Wall St.
Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States and France. The company operates through two segments, Finished Pharmaceutical Products and Active Pharmaceutical Ingredients products. It offers enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; naloxone for opioid overdose; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; lidocaine jelly, a local anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection for newborn babies; and morphine, atropine, calcium chloride, dextrose, epinephrine, lidocaine, and sodium bicarbonate for emergency use in hospital settings; lorazepam injection for surgery and medical procedures. In addition, it offers procainamide for documented ventricular arrhythmias; neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; medroxyprogesterone acetate injectable suspension for the prevention of pregnancy; and isoproterenol hydrochloride injection for mild or transient episodes of heart block, as well as recombinant human and porcine insulins. Further, the company has a pipeline of 20 product candidates in various stages of development for various indications. Its products are used in hospital or urgent care clinical settings, and primarily contracted and distributed through group purchasing organizations and drug wholesalers. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shandell Jason B.President and General CounselJul 10Sale20.316,615134,333154,443Jul 12 07:05 PM
Zhou RongEVP, Production CenterMay 06Option Exercise20.269,600194,49666,707May 07 08:25 PM
Zhou RongEVP, Production CenterMay 06Sale22.769,600218,49657,107May 07 08:25 PM
Shandell Jason B.President and General CounselMay 01Option Exercise10.9310,000109,300169,947May 02 04:07 PM
Shandell Jason B.President and General CounselMay 01Sale21.9710,000219,700159,947May 02 04:07 PM
Shandell Jason B.President and General CounselApr 16Sale20.679,478195,879159,947Apr 18 04:05 PM
Zhang Jack Y.CEO & Chief Scientific OfficerMar 15Option Exercise15.84224,7373,559,8341,591,443Mar 18 07:53 PM
Zhang Jack Y.CEO & Chief Scientific OfficerMar 15Option Exercise15.84514,7838,154,1632,587,100Mar 18 07:53 PM
Shandell Jason B.President and General CounselMar 15Option Exercise10.9324,508267,872184,998Mar 18 07:56 PM
Shandell Jason B.President and General CounselMar 15Sale20.3424,508498,441160,490Mar 18 07:56 PM
Shandell Jason B.President and General CounselMar 14Sale20.377,828159,489160,490Mar 18 07:56 PM
PETERS WILLIAM JCFO, SVP & TreasurerMar 04Option Exercise13.351,50020,02577,050Mar 06 05:20 PM
PETERS WILLIAM JCFO, SVP & TreasurerMar 04Sale25.361,50038,03775,550Mar 06 05:20 PM
Shandell Jason B.President and General CounselMar 01Option Exercise20.267,500151,950175,818Mar 01 08:01 PM
Zhou RongEVP, Production CenterMar 01Option Exercise20.263,20064,83255,230Mar 04 08:44 PM
Shandell Jason B.President and General CounselMar 01Sale24.997,500187,425168,318Mar 01 08:01 PM
Zhou RongEVP, Production CenterMar 01Sale25.003,20080,00052,030Mar 04 08:44 PM
PETERS WILLIAM JCFO, SVP & TreasurerFeb 15Option Exercise13.3510,016133,71485,566Feb 15 08:09 PM
PETERS WILLIAM JCFO, SVP & TreasurerFeb 15Sale24.3710,016244,09075,550Feb 15 08:09 PM
Liawatidewi YakobSVP Corp Admin CenterFeb 14Option Exercise14.954,86872,77740,751Feb 14 06:30 PM
Shandell Jason B.President and General CounselFeb 14Sale23.997,519180,381168,318Feb 15 04:56 PM
Liawatidewi YakobSVP Corp Admin CenterFeb 14Sale24.004,868116,83235,883Feb 14 06:30 PM
Liawatidewi YakobSVP Corp Admin CenterFeb 12Option Exercise14.954,00059,80039,883Feb 14 06:30 PM
Liawatidewi YakobSVP Corp Admin CenterFeb 12Sale23.704,00094,80035,883Feb 14 06:30 PM
Zhou RongEVP, Production CenterFeb 05Option Exercise20.263,20064,83256,319Feb 07 04:05 PM
Liawatidewi YakobSVP Corp Admin CenterFeb 05Option Exercise10.489,817102,88247,280Feb 06 08:12 PM
Liawatidewi YakobSVP Corp Admin CenterFeb 05Sale23.1811,397264,16735,883Feb 06 08:12 PM
Zhou RongEVP, Production CenterFeb 05Sale23.004,28998,64752,030Feb 07 04:05 PM
Liawatidewi YakobSVP Corp Admin CenterJan 23Option Exercise10.484,00041,92041,463Jan 24 08:47 PM
Shandell Jason B.President and General CounselJan 23Sale22.3915,497347,019168,318Jan 25 04:11 PM
Liawatidewi YakobSVP Corp Admin CenterJan 23Sale22.654,00090,60037,463Jan 24 08:47 PM
Liawatidewi YakobSVP Corp Admin CenterJan 22Option Exercise10.483,00031,44040,463Jan 24 08:47 PM
Liawatidewi YakobSVP Corp Admin CenterJan 22Sale22.353,00067,05037,463Jan 24 08:47 PM
Liawatidewi YakobSVP Corp Admin CenterJan 16Option Exercise10.483,17533,27440,638Jan 16 07:10 PM
Liawatidewi YakobSVP Corp Admin CenterJan 16Sale22.153,17570,32637,463Jan 16 07:10 PM
Liawatidewi YakobSVP Corp Admin CenterJan 14Option Exercise10.4888437,471Jan 16 07:10 PM
Liawatidewi YakobSVP Corp Admin CenterJan 14Sale22.15817737,463Jan 16 07:10 PM
PETERS WILLIAM JCFO, SVP & TreasurerJan 02Sale19.523,24563,35475,550Jan 04 05:04 PM
PRINS RICHARD KDirectorDec 14Sale20.651,61633,37033,818Dec 17 08:05 PM
Zhang Jack Y.CEO & Chief Scientific OfficerDec 14Sale20.4843,577892,3092,072,317Dec 17 08:02 PM
Zhang Jack Y.CEO & Chief Scientific OfficerDec 13Sale20.9929,689623,1667,327,679Dec 13 08:08 PM
Applied Physics & Chemistry La10% OwnerDec 13Sale20.9929,689623,1667,327,679Dec 13 08:05 PM
Applied Physics & Chemistry La10% OwnerDec 12Sale21.2137,469794,7367,357,368Dec 13 08:05 PM
Zhang Jack Y.CEO & Chief Scientific OfficerDec 12Sale21.2137,469794,7367,357,368Dec 13 08:08 PM
Koo RichardDirectorDec 11Option Exercise14.6629,278429,215271,206Dec 12 08:39 PM
Zhang Jack Y.CEO & Chief Scientific OfficerDec 11Sale21.4766,7571,433,1507,394,837Dec 13 08:08 PM
Applied Physics & Chemistry La10% OwnerDec 11Sale21.4766,7571,433,1507,394,837Dec 13 08:05 PM
Koo RichardDirectorDec 11Sale21.3229,278624,075241,928Dec 12 08:39 PM
Shohet Stephen B.DirectorDec 10Option Exercise14.6658,557858,44689,263Dec 12 08:37 PM
Shohet Stephen B.DirectorDec 10Sale21.7258,5571,271,78230,706Dec 12 08:37 PM
Lee HowardDirectorDec 07Option Exercise14.669,278136,015132,659Dec 07 06:36 PM
Lee HowardDirectorDec 07Sale21.899,278203,064123,381Dec 07 06:36 PM
Lee HowardDirectorDec 06Option Exercise14.6610,000146,600133,381Dec 07 06:36 PM
Lee HowardDirectorDec 06Sale21.2210,000212,242123,381Dec 07 06:36 PM
Lee HowardDirectorDec 04Option Exercise14.6610,000146,600133,381Dec 07 06:36 PM
Lee HowardDirectorDec 04Sale21.9210,000219,158123,381Dec 07 06:36 PM
PETERS WILLIAM JCFO, SVP & TreasurerDec 03Option Exercise11.3310,000113,30088,795Dec 04 09:00 PM
Shandell Jason B.President and General CounselDec 03Option Exercise10.4816,630174,282200,445Dec 06 03:54 PM
Petersen Floyd F.DirectorDec 03Option Exercise14.6629,278429,215100,429Dec 04 09:01 PM
PETERS WILLIAM JCFO, SVP & TreasurerDec 03Sale22.4010,000224,00178,795Dec 04 09:00 PM
Zhou RongEVP, Production CenterDec 03Sale22.001,08923,95853,119Dec 06 03:56 PM
Shandell Jason B.President and General CounselDec 03Sale22.4416,630373,177183,815Dec 06 03:54 PM
Liawatidewi YakobSVP Corp Admin CenterNov 30Option Exercise20.2611,500232,99048,963Dec 03 08:08 PM
Liawatidewi YakobSVP Corp Admin CenterNov 30Sale21.482,48053,2696,369Dec 03 08:08 PM
Liawatidewi YakobSVP Corp Admin CenterNov 30Sale21.5011,500247,24437,463Dec 03 08:08 PM
PRINS RICHARD KDirectorNov 29Option Exercise14.665,00073,30040,434Nov 30 04:15 PM
PRINS RICHARD KDirectorNov 29Sale20.505,000102,50035,434Nov 30 04:15 PM
Liawatidewi YakobSVP Corp Admin CenterNov 28Sale20.491,52031,1408,849Nov 29 06:12 PM
Liawatidewi YakobSVP Corp Admin CenterNov 23Sale20.261,29926,31537,463Nov 26 08:48 PM
PRINS RICHARD KDirectorNov 14Option Exercise14.665,00073,30040,434Nov 15 07:21 PM
ZASLOFF MICHAEL ADirectorNov 14Option Exercise14.6629,278429,21559,123Nov 15 07:23 PM
ZASLOFF MICHAEL ADirectorNov 14Sale20.3929,278596,94929,845Nov 15 07:23 PM
PRINS RICHARD KDirectorNov 14Sale20.235,000101,16735,434Nov 15 07:21 PM
Shandell Jason B.President and General CounselNov 14Sale20.4116,015326,855183,490Nov 15 07:20 PM
PETERS WILLIAM JCFO, SVP & TreasurerNov 12Sale20.613,17265,36678,152Nov 13 05:09 PM
Shandell Jason B.President and General CounselNov 09Option Exercise10.4616,095168,354215,600Nov 09 09:52 PM
Liawatidewi YakobSVP Corp Admin CenterNov 09Option Exercise14.329,807140,38750,570Nov 13 05:08 PM
PETERS WILLIAM JCFO, SVP & TreasurerNov 09Option Exercise11.3310,000113,30091,324Nov 13 05:09 PM
PETERS WILLIAM JCFO, SVP & TreasurerNov 09Sale21.4710,000214,72381,324Nov 13 05:09 PM
Zhou RongEVP, Production CenterNov 09Sale21.001,08922,86953,303Nov 13 05:10 PM
Liawatidewi YakobSVP Corp Admin CenterNov 09Sale21.2111,808250,42138,762Nov 13 05:08 PM
Shandell Jason B.President and General CounselNov 09Sale20.9916,095337,834199,505Nov 09 09:52 PM
Shandell Jason B.President and General CounselNov 08Option Exercise10.6536,201385,711235,706Nov 09 09:52 PM
Liawatidewi YakobSVP Corp Admin CenterNov 08Option Exercise11.416,00068,46046,763Nov 13 05:08 PM
PETERS WILLIAM JCFO, SVP & TreasurerNov 08Option Exercise11.3319,800224,334106,636Nov 13 05:09 PM
Zhou RongEVP, Production CenterNov 08Sale20.001,08421,68054,392Nov 13 05:10 PM
PETERS WILLIAM JCFO, SVP & TreasurerNov 08Sale20.4625,312517,88381,324Nov 13 05:09 PM
Liawatidewi YakobSVP Corp Admin CenterNov 08Sale20.506,000123,00040,763Nov 13 05:08 PM
Shandell Jason B.President and General CounselNov 08Sale20.6836,201748,586199,505Nov 09 09:52 PM
PETERS WILLIAM JCFO, SVP & TreasurerAug 16Sale17.592,40742,33386,836Aug 17 04:05 PM
PRINS RICHARD KDirectorAug 14Option Exercise14.6610,000146,60045,434Aug 15 04:29 PM
PRINS RICHARD KDirectorAug 14Sale17.8210,000178,18035,434Aug 15 04:29 PM